New faculty who joined VP&S in April and June include an emergency medicine doctor and a radiologist who has helped translate state-of-the-art imaging techniques.
New faculty who joined VP&S in February and March include the chair of the Department of Radiology and the vice chair for basic research in the Department of Pediatrics.
New faculty who joined VP&S in recent months include a specialist in managing infections in immunocompromised patients and a researcher of precision cellular immunotherapies for autoimmunity.
Riders, sponsors, volunteers, and friends joined forces for Velocity, Columbia's Ride to End Cancer, in support of the Herbert Irving Comprehensive Cancer Center.
Jeffrey Hall, Michael Rosbash, and Michael Young were awarded the 2017 Nobel Prize in Physiology or Medicine for their discoveries of molecular mechanisms controlling circadian rhythm.
Cancer immunotherapy drugs only work for a minority of patients, but a generic drug now used to increase blood flow may be able to improve those odds, a study by Columbia University Medical Center researchers suggests.
Immunotherapy expert Pawel Muranski speaks about the new CAR-T therapy for leukemia and his work to bring T cell therapies to patients with a wide range of cancers.